Back Bay Scientific's approach to product development starts in the laboratory with the discovery that a particular food constituent normally affects some aspect of the biochemistry and physiology of the brain. It continues with the demonstration that this response also occurs in people, and the recognition that the constituent can thus be used to help people who are either deficient in the compound (for example, older people with low nighttime blood melatonin levels), or who would benefit from having more of something the brain makes from the compound (for example, serotonin and certain other neurotransmitters). A prototype product containing the compound is then tested in people, using double-blind, placebo-controlled protocols, and appropriate patent applications are filed. The results of the controlled clinical studies are then published in peer-reviewed journals.
Back Bay Scientific's rigorous scientific process sets it apart from its competitors and allows for the substantiation of product claims that satisfy government regulators and the medical community.
Back Bay Scientific clinical scientists first showed in laboratory studies that:
Back Bay Scientific's current and in-development products are based on the following compounds:
Back Bay Scientific Kendal Square Box 425307, Cambridge, Massachusetts, 02142, USA